Bart-VEGF-driven angioproliferation on a constitutive GET (Generalized Essential Telangiectasia) substrate, vertically inherited from father. HHT effectively ruled out across the entire paternal line (Patrick mucosa clean + no self-epistaxis · father same skin but NO nosebleeds 2026-05-24 · brother's childhood nosebleeds reframed as benign).
NOS3 rs891512 A;G · L-citrulline response · PEA partial signature · 3-part BBB kill signature · 7 vasculopathy findings 2026-05-23 (nailfold + spider angiomas diascopy-positive + chronic red eyes + father pasty-redness + cherry-onset-30 + shoulder anatomic clustering + scalloped tongue) · mucosa clean (HHT ruled out for Patrick).
HLA-B27 tag + 4.6× AS + 5.2× RA + IL23R + 1.78× ITGAM SLE + grandmother arthritis. Layered on top of Bart-primary.
Age-6 panic + age-6 shingles as single CNS event. OXTR + brother schizophrenia. Magtein NMDA signature validates centrally-driven.
Same NOS3 — vascular expression of Bart-primary, not separate hypothesis.
DIO1 A;A + 2 thyroid Ca variants + grandfather Hx. Metabolic capacity floor.
Throttle, not root. Partially explained by autoimmune cluster + Bart-driven mast cell.
CCR5Δ32 + IL12B + CCL2 permissive niche. Tyrosine-load home test pending.
KIBRA + APOE protective — glymphatic not the bottleneck.
2× home urine porphyrin clean → effectively falsified.
When a BBB-crossing antimicrobial works: (1) easy breathing · (2) lower-back unsticking · (3) head clearing. Convergent on Bart-endothelial + perivascular mast-cell release simultaneously in pulmonary microvasc / lumbar paraspinal / cerebral microvasc.
Textbook refill-from-center wagon-wheel on spider angiomas (Bart-VEGF pattern). Cherry dots resist blanching even under firm pressure (venular pooling, less specific). Cherry onset since ~age 30, spider lesions earlier — longitudinal anchor of chronic-progressive vasculopathy. Anatomic clustering on shoulder/above-scapula.
Lip · vermilion · gingiva · palate · tongue · nasal vestibule all CLEAN of HHT-pattern pinpoint telangiectasias. Cross-checked by recent dentist visit (independent observer). Curaçao criteria un-satisfied. HHT effectively ruled out for Patrick.
Father shares SKIN phenotype (pasty with redness). Constitutive familial substrate confirmed (= GET-Bart layered model wins, Anthropic R8 framework). Nosebleed Q to father pending — would close the HHT-in-family check.
Bart drives angiogenesis via VEGF. Direct biochemical test — should confirm what nailfold + spider + diascopy showed visually.
Father confirms NO history of spontaneous nosebleeds. HHT autosomal dominant + ~90% epistaxis penetrance by 40 → father not a carrier → HHT effectively ruled out across the entire paternal line. Brother's childhood nosebleeds + fainting reframed as benign childhood phenomena (very common 8-15yo) + vasovagal pre-syncope, NOT HHT inheritance. The GET (constitutive vascular-skin trait) substrate hypothesis WINS cleanly: father has same trait without HHT, Patrick inherited trait + got Bart layer on top.
Day A: 1.5g L-tyrosine. Day B: 1.5g L-leucine control. Count loops + Bart-laugh in 10-min windows over 3h.
Supine 5min → seated 5min → standing 5min → 2-min brisk walk. SpO2 + HR. With scalloped tongue + photic somnolence + HNO sleep test pending → repurposed for UARS daytime baseline rather than pulmonary AVM (HHT already ruled out).
Brother had childhood spontaneous nosebleeds + ~bimonthly fainting + 2 untreated tick bites + schizophrenia + severe dermatitis. Most parsimonious: vertical Bart to both + HHT autosomal-dominant to brother only. ArminLabs LTT for brother would be high-leverage if he's open. Brother's nosebleed frequency NOW would close the family Curaçao score. R9 script (HHT-only, no Bart, no genetics): "Hey — I read something about childhood nosebleeds + fainting being a vascular thing that runs in families and is actually treatable. There's a 4-question checklist called Curaçao criteria…"
R9 lateral move: Bart parasitizes lymphatic endothelial cells (LECs) via VEGFR-3 — lymphangiogenesis is the under-discussed half of bartonellosis. Your shoulder/scapula spider cluster sits directly over the supraclavicular lymphatic drainage field for head, neck, ipsilateral arm. Photic somnolence + sticky thoughts + 3-part BBB sig may all converge on glymphatic outflow restriction via cervical-lymph congestion. Tests: cervical palpation + photo-map · Stemmer sign on toe webs + finger web spaces · sternal pinch test · manual cervical lymph drainage (Vodder-style) 2 min/day × 7.
R9 most-decisive 30-day evidence: 2mm punch of scapular spider body. Send for Bartonella PCR + FISH + Warthin-Starry + VEGF immunostain. Positive = near-definitive Bart-vasculopathy confirmation.
Standardized photos of scapular spider cluster at day 0, 14, 21, 30, 60. Fixed camera distance, ruler in frame, same lighting. Count + diameter-measure every lesion ≥2mm. ≥20% count drop by day 30 = model confirmed. Cherry angiomas often ignore systemic change — focus on SPIDERS.
Two of three R10 models punched UCTD / autoimmune microangiopathy as the strongest alternative root-cause. One punched CIRS / biotoxin. The 97% Bart-vasculopathy model has real evidence — but no microbiologic anchor + non-discriminating drug response. R10 added 3 cheap tests that would either survive (→ 99%+) or collapse (→ 30-40%) the model.
R10 OpenAI + Gemini convergent punch. Anti-Centromere, Scl-70 (systemic sclerosis), SSA/SSB (Sjögren). Standard rheumatology workup. Patient has never had this done.
R10 Anthropic punch: VCS positive (60/90, biotoxin 64%, R>L) + 17y mold + mother CFS = CIRS-cohort pattern. Lab via IMD Berlin or Ganzimmun.
R10 OpenAI: standardized 8-finger × 4-photo capillaroscopy with rheumatologist Cutolo scoring. The eye-level read of "spider angioma + asymmetric capillaries" is NOT a Cutolo score. Definite scleroderma pattern (giant loops + microhemorrhages + dropout / avascular areas) = autoimmune microangiopathy confirmed.
R10 Anthropic: 2-week binder trial with strict timing isolation from herbs. Run during MB off-week 1 (7-day window after cycle 1). CIRS responders feel it in days; pure Bart-primary patients don't.
Council history: personal/_archive/ · ground truth: 85 entries · design explorations